Compare · HSIC vs MCK
HSIC vs MCK
Side-by-side comparison of Henry Schein Inc. (HSIC) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. HSIC focuses on Medical Specialities, while MCK focuses on Other Pharmaceuticals.
- MCK is the larger of the two at $94.41B, about 10.2x HSIC ($9.25B).
- Over the past year, HSIC is up 15.7% and MCK is up 8.5% - HSIC leads by 7.1 points.
- MCK has been more active in the news (25 items in the past 4 weeks vs 5 for HSIC).
- Both have 25 recent analyst ratings on file.
- Company
- Henry Schein Inc.
- McKesson Corporation
- Price
- $81.17+0.10%
- $785.59+0.78%
- Market cap
- $9.25B
- $94.41B
- 1M return
- +11.64%
- +3.26%
- 1Y return
- +15.68%
- +8.53%
- Industry
- Medical Specialities
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 1995
- News (4w)
- 5
- 25
- Recent ratings
- 25
- 25
Henry Schein Inc.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest HSIC
- Director Daniel William K was granted 2,215 shares, increasing direct ownership by 41% to 7,641 units (SEC Form 4)
- Henry Schein upgraded by BTIG Research with a new price target
- SEC Form SD filed by Henry Schein Inc.
- New insider Murphy Kelly Ann claimed ownership of 34,812 shares (SEC Form 3)
- Amendment: Former Director Bergman Stanley M gifted 50 shares, decreasing direct ownership by 0.02% to 253,279 units (SEC Form 4)
- Director Bergman Stanley M gifted 50 shares, decreasing direct ownership by 0.02% to 253,279 units (SEC Form 4)
- Henry Schein Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board
- Director Bergman Stanley M gifted 1,040 shares, decreasing direct ownership by 0.41% to 253,329 units (SEC Form 4)
- Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth
Latest MCK
- SEC Form DEFA14A filed by McKesson Corporation
- SEC Form DEF 14A filed by McKesson Corporation
- McKesson Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Executive Officer Tyler Brian S. sold $3,760,827 worth of shares (4,929 units at $763.00) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 22,845 units (SEC Form 4)
- SVP, Controller & CAO Rutledge Napoleon B Jr sold $101,612 worth of shares (133 units at $764.00) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 632 units (SEC Form 4)
- EVP, Chief Strategy & BDO Rodgers Thomas L sold $604,420 worth of shares (822 units at $735.30) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 2,268 units (SEC Form 4)
- EVP & Chief HR Officer Smith Leann B sold $1,331,255 worth of shares (1,810 units at $735.50) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 4,798 units (SEC Form 4)
- McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions
- SEC Form 4 filed by EVP & CFO Cheung Kenny K
- SEC Form 3 filed by new insider Cheung Kenny K